What was the market valuation of the US opioid withdrawal-treatment market in 2024?

The market valuation was $675.69 Million in 2024. Read More

What is the projected market valuation for the US opioid withdrawal-treatment market by 2035?

The projected valuation for 2035 is $1,173.96 Million. Read More

What is the expected CAGR for the US opioid withdrawal-treatment market during the forecast period 2025 - 2035?

The expected CAGR is 5.15% during the forecast period 2025 - 2035. Read More

Which treatment types contributed to the market in 2024?

In 2024, medications contributed $300.0 - $500.0 Million, therapeutic procedures $150.0 - $250.0 Million, psychological counseling $125.0 - $200.0 Million, and support groups $100.0 - $223.96 Million. Read More

What are the leading routes of administration for opioid withdrawal treatments?

The leading routes of administration include oral ($135.0 - $225.0 Million), injectable ($180.0 - $300.0 Million), transdermal ($90.0 - $150.0 Million), and nasal ($270.69 - $478.96 Million). Read More

How did the patient type segmentation perform in 2024?

In 2024, outpatient treatments generated $300.0 - $500.0 Million, inpatient treatments $135.69 - $230.96 Million, and emergency treatments $240.0 - $443.0 Million. Read More

What age groups are targeted in the US opioid withdrawal-treatment market?

The market targets children ($50.0 - $80.0 Million), adolescents ($100.0 - $150.0 Million), adults ($400.0 - $650.0 Million), and the elderly ($125.69 - $193.96 Million). Read More

Who are the key players in the US opioid withdrawal-treatment market?

Key players include Indivior PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Alkermes PLC, Purdue Pharma L.P., Horizon Therapeutics PLC, NantKwest Inc., and Camurus AB. Read More

What trends are expected in the US opioid withdrawal-treatment market by 2035?

By 2035, the market is likely to expand significantly, driven by an increasing focus on effective treatment options and a projected valuation of $1,173.96 Million. Read More

How does the market's growth potential appear in the context of current treatment options?

The market's growth potential appears robust, with a projected CAGR of 5.15% indicating a sustained demand for innovative treatment solutions. Read More

US Opioid Withdrawal Treatment Market

ID: MRFR/HC/16106-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Opioid Withdrawal Treatment Market Research Report By Treatment Type (Medications, Therapeutic Procedures, Psychological Counseling, Support Groups), By Route of Administration (Oral, Injectable, Transdermal, Nasal), By Patient Type (Inpatient, Outpatient, Emergency) and By Age Group (Children, Adolescents, Adults, Elderly) - Growth & Industry Forecast 2025 To 2035

US Opioid Withdrawal Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Treatment Type (USD Million)
  1. 4.1.1 Medications
  2. 4.1.2 Therapeutic Procedures
  3. 4.1.3 Psychological Counseling
  4. 4.1.4 Support Groups
2. 4.2 Food, Beverages & Nutrition, BY Route of Administration (USD Million)
  1. 4.2.1 Oral
  2. 4.2.2 Injectable
  3. 4.2.3 Transdermal
  4. 4.2.4 Nasal
3. 4.3 Food, Beverages & Nutrition, BY Patient Type (USD Million)
  1. 4.3.1 Inpatient
  2. 4.3.2 Outpatient
  3. 4.3.3 Emergency
4. 4.4 Food, Beverages & Nutrition, BY Age Group (USD Million)
  1. 4.4.1 Children
  2. 4.4.2 Adolescents
  3. 4.4.3 Adults
  4. 4.4.4 Elderly
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Indivior PLC (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mylan N.V. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Alkermes PLC (IE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Purdue Pharma L.P. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Horizon Therapeutics PLC (IE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 NantKwest Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Camurus AB (SE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TREATMENT TYPE
3. 6.3 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 US MARKET ANALYSIS BY PATIENT TYPE
5. 6.5 US MARKET ANALYSIS BY AGE GROUP
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY PATIENT TYPE, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY AGE GROUP, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY AGE GROUP, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY PATIENT TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Treatment Type (USD Million, 2025-2035)

Medications
Therapeutic Procedures
Psychological Counseling
Support Groups

Food, Beverages & Nutrition By Route of Administration (USD Million, 2025-2035)

Oral
Injectable
Transdermal
Nasal

Food, Beverages & Nutrition By Patient Type (USD Million, 2025-2035)

Inpatient
Outpatient
Emergency

Food, Beverages & Nutrition By Age Group (USD Million, 2025-2035)

Children
Adolescents
Adults
Elderly

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”